Esophageal Reflux Barrier Might be More than Just An Anatomical Definition: A Systematic Literature Review
Abstract
BACKGROUND
Gastroesophageal reflux disease (GERD) is a common condition that affects millions of people worldwide. It can be stated that a defective esophageal reflux barrier (ERB) is the primary cause that can lead to these disease entities. The goal of this systematic review was to summarize and investigate the current literature regarding the functional and molecular aspects of the ERB in humans and the influence of anti-reflux surgery (ARS) on its improvement.
MATERIALS AND METHODS
Pubmed, Embase, MEDLINE, and the Cochrane Library were searched from the earliest available date of each database through April 12, 2026. Outcome measurements of interest were changes in the molecular and cellular components of the ERB, as well as improvement in GERD symptoms measured objectively or subjectively.
RESULTS
The primary literature search produced 110 results, including six duplicates. After screening on title and abstract, 15 studies were found possibly relevant and underwent full-text critical appraisal, resulting in 14 exclusions. Only the study by Ergun et al. fulfilled the inclusion criteria and was therefore included in this systematic review. This study showed significant improvements after ARS in mucosal integrity, mucosal permeability, and mRNA gene expression of the following molecules: E-cadherin, occludin, claudin 1, claudin 4, zonula occludens-1 and zonula occludens-2.
CONCLUSION
ARS is responsible for many anatomical and physiological mechanisms, many of which are not…
Read the paper
Related studies
- Advantages and Disadvantages of Long-term Proton Pump Inhibitor Use
- Ivth brazilian consensus conference on helicobacter pylori infection
- A pSMAD/CDX2 complex is essential for the intestinalization of epithelial metaplasia
- S2k-Leitlinie Gastroösophageale Refluxkrankheit und eosinophile Ösophagitis der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) – März 2023 – AWMF-Registernummer: 021–013
- Step-by-step management of refractory gastresophageal reflux disease
- Insights into Effects/Risks of Chronic Hypergastrinemia and Lifelong PPI Treatment in Man Based on Studies of Patients with Zollinger–Ellison Syndrome
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.